Send Message
View as an RSS Feed
  • Despite Positive Phase 3 Results, Radius Health May Warrant A Short Sale  [View article]
    You failed to note that one of the premier biotech analysts for the last 20+ years on Wall Street---Dr. Eric Schmidt of Cowen---says that RDUS should trade to the low $60s after this very important data was announced. It is very rare that Schmidt is ever this aggressive on a biotech stock.
    RDUS is moving up in value as the assets are clearly worth more to an acquirer --- such as LLY -- than as a stand-alone. Also, this data de-risks a substantial drug. It does not appear that LLY's Forteo was able to hit these endpoints & LLY should consider buying RDUS if they want to extend the life of Forteo---which does go off patent in 2018.
    Dec 31, 2014. 08:30 AM | 2 Likes Like |Link to Comment
  • DynaVax Technologies: The Small Cap Gem Focus Stock Of The Week  [View article]
    You should go back & review your original comments on this as well as the posted commentary. It appears that you failed to peal back the onion on this the last time you recommended this---CEO forced out, unsuccessful company sale, difficulty in attracting new leadership. This may work a bit better this time but more due diligence is necessary so retail investors don't get led once again to being slaughtered.
    Dec 10, 2014. 03:08 PM | 5 Likes Like |Link to Comment
  • Zacks' Bull Of The Day: American Airlines  [View article]
    AAL flies planes every day----do you even follow this company or the group ??? Did you miss that AAL has a buyback program in place, pays a dividend, is modernizing their fleet while paying down debt ? Did you happen to notice that AAL has a $36 Billion market cap ? Projections are unreliable at the current time ???? Clearly you missed this one !
    Dec 10, 2014. 01:45 PM | Likes Like |Link to Comment
  • Zacks' Bull Of The Day: American Airlines  [View article]
    BankofAmerica Merrill Lynch finally upgraded AAL today with a BUY $55 target. I wonder what they've been thinking THIS YEAR ????
    Dec 1, 2014. 05:17 PM | 1 Like Like |Link to Comment
  • Why Alexion Is A Buy  [View article]
    hasn't the stock just popped over 20 points since ALXN reported earnings TWO WEEKS AGO ???
    Nov 5, 2014. 09:10 AM | Likes Like |Link to Comment
  • Why Alexion Is A Buy  [View article]
    flip flop
    Nov 5, 2014. 09:07 AM | Likes Like |Link to Comment
  • AcelRx Pharmaceutical's Potential Billion-Dollar Treatment Under The Radar  [View article]
    Has ACRX been moved to your scrap heap ? It sure looked like a fun story.
    Oct 23, 2014. 09:20 PM | Likes Like |Link to Comment
  • Finding Small Cap Gems Within Biotech  [View article]
    You've written extensively on DVAX in the past----is this one ever going to make it ? I don't think I have two decades to wait to see if its the next GILD.
    Sep 20, 2014. 10:01 AM | 1 Like Like |Link to Comment
  • Alexion Pharmaceuticals: 4 Different Insiders Have Sold Shares During The Last 30 Days  [View article]
    Do you remotely understand that when insiders have exercised stock that stock is AUTOMATICALLY sold to pay the taxes due on exercise. This may be a complicated process for those not familiar with how people running public companies are paid---salary, potential bonus, equity stock. As far as option exercises please learn how to distinguish the DIFFERENT types of exercise and the resulting investment implications. That may help you understand what is actually taking place.
    Sep 8, 2014. 04:06 PM | Likes Like |Link to Comment
  • Weatherford Makes Big Steps Towards Financial Objectives  [View article]
    Huge option buying today in the out-of-the-money OCT WFT calls---more than 40,000 total---with one trader buying 15,000. Throw in Mario Gabelli's comments that he sees HAL buying WFT up 50% & the stock waking up from its consolidation & you have a stock ready to go back on the New High list. Momentum players anyone ?
    Aug 27, 2014. 05:06 PM | Likes Like |Link to Comment
  • Alexion Looks Better After Q2 Earnings  [View article]
    You must not follow ALXN very closely and failed to notice that the stock ran almost 20 points prior to earnings. Do you know what at about the ultra rare orphan drug space that that made shareholders very happy ?? Maybe you should follow utilities.
    Jul 28, 2014. 05:08 PM | Likes Like |Link to Comment
  • Why I Have Re-Entered Sarepta Therapeutics  [View article]
    SRPT will sure be "on sale" today !!
    Jul 10, 2014. 09:27 AM | 1 Like Like |Link to Comment
  • AcelRx Pharmaceuticals To Submit NDA By End Of September, May Be Acquired Soon  [View article] wait until ACRX pops 3 points before commenting. Funny world !
    Jul 6, 2014. 08:15 PM | Likes Like |Link to Comment
  • AcelRx Pharmaceuticals To Submit NDA By End Of September, May Be Acquired Soon  [View article]
    Just curious---did you stop following ACRX ?????? Lots of comments were made but nothing in quite some time. Was something misplaced ???
    Jun 23, 2014. 10:31 PM | Likes Like |Link to Comment
  • American Airlines Group: A Strong Buy  [View article]
    The recent seat price hikes in the US should benefit AAL as they have 70% exposure to N. America. Much of he increases will off-set fuel costs which have crept up to above $3/gal. Many analysts are currently modeling $3.07-3.12/gal in their estimates so that currently not that big of an issue.
    US traffic continues to expand strongly & their N. American alliances are also doing well. Also, as AAL is a post-bankruptcy company many institutional investors are not allowed by charter to invest at this time, leaving AAL dramatically lower in institutional holders than DAL, LUV, UAL. That should change in time (especially if AAL is added to the S&P 500). On top of that you have many synergies on the horizon---especially in 2015. This all sets up AAL to generating EPS of $7/share in time---which can give a reasonable valuation of $55-70/share over the next 12-18 months.
    Jun 19, 2014. 08:51 PM | 1 Like Like |Link to Comment